GM27895
Fibroblast from Skin, Skin
Description:
VICI SYNDROME; VICIS
|
Repository
|
NIGMS Human Genetic Cell Repository
|
| Subcollection |
Heritable Diseases
PIGI Consented Sample |
|
Biopsy Source
|
Skin
|
|
Cell Type
|
Fibroblast
|
|
Tissue Type
|
Skin
|
|
Transformant
|
Untransformed
|
|
Sample Source
|
Fibroblast from Skin, Skin
|
|
Race
|
White
|
|
Ethnicity
|
Ashkenazi Jewish
|
|
Country of Origin
|
USA
|
|
Family Member
|
4
|
|
Family History
|
N
|
|
Relation to Proband
|
sister
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Remarks
|
|
| PDL at Freeze |
5.26 |
| Passage Frozen |
3 |
| |
| IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
| |
| Remarks |
Unaffected family member; sister of affected brother GM26249 (lymph), GM26636 (fibroblast) and GM27291 (stem cell); unaffected carrier father is GM26250 (lymph) and GM27895 (fibro); unaffected carrier mother is GM26251 (lymph); PMID# 31226715. |
| Kane MS, Zhao J, Muskett J, Diplock A, Srivastava S, Hauser N, Deeken JF, Niederhuber JE, Smith WE, Vilboux T, Ebrahimi-Fakhari D, EPG5 Variants with Modest Functional Impact Result in an Ameliorated and Primarily Neurological Phenotype in a 35-Year-Old Patient with Vici Syndrome Neuropediatrics50:257-261 2019 |
| PubMed ID: 31226715 |
| Passage Frozen |
3 |
| Split Ratio |
1:3 |
| Temperature |
37 C |
| Percent CO2 |
5% |
| Percent O2 |
AMBIENT |
| Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
| Serum |
15% fetal bovine serum Not inactivated |
| Supplement |
- |
|
|